Detailed analysis of the “Drugs for Malaria Market” helps to understand the various types of Drugs for Malaria products that are currently in use, along with the variants that would gain prominence in the future.
Request for sample PDF Here: http://www.arcognizance.com/enquiry-sample/104147
In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Drugs for Malaria market for 2018-2023.
Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease.
Anti-malarial Drugs are available only with a physician’s prescription. They come in tablet, capsule, and injectable forms. Among the commonly used anti-malarial drugs are chloroquine, mefloquine, primaquine, pyrimethamine, and quinine.
The classification of drugs for malaria includes aryl aminoalcohol compounds, antifolate compounds and artemisinin compounds. The proportion of aryl aminoalcohol compounds drugs for malaria in 2016 is about 16.8%, the proportion of antifolate compounds in 2016 is about 55.4% and the proportion of artemisinin compounds in 2016 is about 27.8%.
Drugs for malaria are application in Preventioning malaria, curing malaria and other areas. The most of drugs for malaria is used in Preventioning malaria; the market share in 2016 is about 56.1%. And 35.1% of drugs for malaria are used in curing malaria.
Browse The Full Report With TOC@ http://www.arcognizance.com/report/2018-2023-global-drugs-for-malaria-consumption-market-report
Market competition is intense. The major manufacturers are Cipla, Guilin Pharmaceutical, IPCA Laboratories, GlaxoSmithKline, Mylan Labs, Roche, Novartis, Sanofi Aventis and Ajanta Pharma in the United States.
Over the next five years, LPI(LP Information) projects that Drugs for Malaria will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs for Malaria market by product type, application, key manufacturers and key regions.
To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:
Segmentation by product type:
Aryl Aminoalcohol Compounds
Antifolate Compounds
Artemisinin Compounds
Segmentation by application:
Prevention
Treatment
Other
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
For Enquiry for Drugs for Malaria Market Report at: http://www.arcognizance.com/enquiry-before-buying/104147
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market.
The key manufacturers covered in this report:
Cipla
Guilin Pharmaceutical
IPCA Laboratories
GlaxoSmithKline
Mylan Labs
Roche
Novartis
Sanofi Aventis
Ajanta Pharma
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Drugs for Malaria consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Drugs for Malaria market by identifying its various subsegments.
Focuses on the key global Drugs for Malaria manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Drugs for Malaria with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Drugs for Malaria submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Purchase Drugs for Malaria Market Report at: http://www.arcognizance.com/purchase/104147
Some Points From TOC:
Chapter One: Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
Chapter Two: Executive Summary
2.1 World Market Overview
2.1.1 Global Drugs for Malaria Consumption 2013-2023
2.1.2 Drugs for Malaria Consumption CAGR by Region
2.2 Drugs for Malaria Segment by Type
2.2.1 Aryl Aminoalcohol Compounds
2.2.2 Antifolate Compounds
2.2.3 Artemisinin Compounds
Chapter Three: Global Drugs for Malaria by Players
3.1 Global Drugs for Malaria Sales Market Share by Players
3.1.1 Global Drugs for Malaria Sales by Players (2016-2018)
3.1.2 Global Drugs for Malaria Sales Market Share by Players (2016-2018)
3.2 Global Drugs for Malaria Revenue Market Share by Players
3.2.1 Global Drugs for Malaria Revenue by Players (2016-2018)
3.2.2 Global Drugs for Malaria Revenue Market Share by Players (2016-2018)
Chapter Four: Drugs for Malaria by Regions
4.1 Drugs for Malaria by Regions
4.1.1 Global Drugs for Malaria Consumption by Regions
4.1.2 Global Drugs for Malaria Value by Regions
4.2 Americas Drugs for Malaria Consumption Growth
4.3 APAC Drugs for Malaria Consumption Growth
Chapter Five: Americas
5.1 Americas Drugs for Malaria Consumption by Countries
5.1.1 Americas Drugs for Malaria Consumption by Countries (2013-2018)
5.1.2 Americas Drugs for Malaria Value by Countries (2013-2018)
5.2 Americas Drugs for Malaria Consumption by Type
5.3 Americas Drugs for Malaria Consumption by Application
5.4 United States
…and Continued
About US:
www.arcognizance.com is an initiation in this new era of “analysis @ thought.” We are on a mission to replace the conventional research programs and give way to the latest methods and information for the organizations. We have created this hub of analytical research papers where you can get an access to the latest and the best research papers coming out from some reliable and budding research houses. After the advent of “new analytics“ based on the data collection facilities of big data, the face of „business research facilities“ has changed drastically. With ARC our experts have created a bookshelf where you can check out the research reports that are an outcome of the progression of knowledge in various industry sectors. Alongside you can also check some research papers, market reports, and forecasts that are talking about the „out of the box“ developments in the market.
Contact US:
Matt Wilson
Manager – Global Sales
Address: 100 Church Street,
8th floor, Manhattan,
New York 10007
Phone: +1 (646) 434-7969 +91 90967 44448
Email: enquiry@arcognizance.com